Posted inFrom the Archive

New Requirements for Drug Manufacturers

The White House and the Food and Drug Administration both released plans aimed at reducing prescription drug abuse in the United States on April 19. The Administration’s Epidemic: Responding to America’s Prescription Drug Crisis expands state-based prescription drug monitoring programs “especially regarding real-time data access by clinicians, and to increase inter-state operability and communication.” The statement […]

Posted inFrom the Archive

03/22/11 – Roundtable Bios

On March 22, 2011, Compliance Week and Crowe Horwath presented an editorial roundtable at the Ritz-Carloton Dallas. More than 10 chief compliance officers attended the discussion, which focused on corporate ethics: understanding it, improving it, and demonstrating it. The forum was moderated by Compliance Week Editor Matt Kelly. Attendees’ full biographies are below. Audrey Andrews […]

Posted inFrom the Archive

Shop Talk: At the Intersection of Ethics and Compliance

These days, after years of pressure from regulators and shareholders, most large public companies have a chief compliance officer with (relatively) clear areas of responsibility and lines of authority. THE PANELISTS The following executives participated in the March 22 roundtable on corporate ethics. Audrey Andrews, Chief Compliance Officer, Tenet Healthcare Bobby Butler, Chief Compliance Officer, […]

Posted inFrom the Archive

Corp Fin Updates Financial Reporting Manual

The Securities and Exchange Commission’s Division of Corporation Finance updated its Financial Reporting Manual on April 4. The new version revises topics including reporting status (according to Section 404 in the Sarbanes-Oxley Act), financial statement requirements for multiple series registrants, income averaging, changes in accountants, and foreign business financial statements, says Melanie Dolan, a partner […]

Gift this article